The 10th Microbiome Movement Summit Europe brings together leading researchers, clinicians, regulatory specialists, and industry pioneers to drive forward the science and commercialization of microbiome-based therapeutics and products.
This event guide offers a clear, practical overview of the three-day program, including the agenda, speaker lineup, core discussion themes, and networking opportunities.
Inside, you’ll find detailed session descriptions covering translational research, clinical development strategies, biomarker discovery, partnership models, regulatory updates, and approaches to scaling innovation from lab to market. These sessions are designed to help attendees gain valuable insights into the key scientific, technical, and strategic forces shaping the future of microbiome healthcare and product development.
This resource is ideal for professionals seeking to:
- Align their organization with emerging scientific and commercial trends
- Identify new collaboration and partnership opportunities
- Prepare for targeted networking and stakeholder engagement at the summit
- Strategically plan their session attendance and on-site schedule
Event overview
- Dates: 27–29th January 2026
- Location: Park Plaza Victoria, London, UK
- Audience: Researchers, biotech and pharmaceutical executives, clinical development leaders, regulatory and policy specialists, strategy and innovation teams, investors, and partners across the microbiome ecosystem
Download the full event guide to explore the full program and start planning your participation. It’s a unique opportunity to connect with key decision-makers, shape the direction of the field, and engage with the forefront of microbiome innovation.
About Hanson Wade Group - 10th Microbiome Movement Summit Europe 2026
Translate the Latest Microbiome Science into Validated Clinical Impact to Strengthen Investor Confidence & Deliver Safe, Effective Microbiome Therapies & Products to Patients in Need
Drawing on a decade of industry experience, the 10th Microbiome Movement Summit Europe returns to London, as the premiere touchpoint for end-to-end discussions in advancing best-in-class microbiome products beyond traditional gastrointestinal indications.
Over the past 10 years, this community has developed robust and impactful preclinical research, now the focus has shifted to translating this into clinical efficacy and driving towards commercial excellence, in spite of industry headwinds.
Join senior stakeholders from across the microbiome field, including drug developers, academics, consumer health, pharma, investors, service providers and more, to overcome shared challenges, spotlight innovations and collaborate in shaping the future of microbiome therapeutics.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.